1. Market Research
  2. > Pathology Industry

Breast Cancer Industry, August 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, Oncology, Mammography, Drug, Biopsy Device, Pharmaceutical, Biomarker, Healthcare, Radiological Equipment, Diagnostic Test, Medical, Molecular Diagnostic, Antibody, Cancer Diagnostic, Clinical Trial, Vaccine, Biochip, Breast Cancer Therapeutics, Genetic, Rnai.


 
1-10 of 95 reports for Breast Cancer

Purchase Reports From Reputable Market Research Publishers

US HER-2 Positive Breast Cancer Industry 2015 Market Research Report

US HER-2 Positive Breast Cancer Industry 2015 Market Research Report

  • $ 3 800
  • Industry report
  • August 2015
  • by QY Research Group

Summary The US HER-2 Positive Breast Cancer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the HER-2 Positive Breast Cancer industry. The report provides ...

Global HER-2 Positive Breast Cancer Industry 2015 Market Research Report

Global HER-2 Positive Breast Cancer Industry 2015 Market Research Report

  • $ 2 800
  • Industry report
  • August 2015
  • by QY Research Group

Summary The Global HER-2 Positive Breast Cancer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the HER-2 Positive Breast Cancer industry. The report provides ...

Global Breast Cancer Industry 2015 Market Research Report

Global Breast Cancer Industry 2015 Market Research Report

  • $ 2 800
  • Industry report
  • August 2015
  • by QY Research Group

Summary The Global Breast Cancer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Breast Cancer industry. The report provides a basic overview of the ...

Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

  • $ 4 795
  • Industry report
  • August 2015
  • by Transparency Market Research

The report on breast cancer therapeutics: pipeline analysis market studies the future market of breast cancer drugs on the basis of the molecules which are currently under pipeline. Breast cancer usually ...

Global Breast Cancer Partnering 2010-2015

Global Breast Cancer Partnering 2010-2015

  • $ 1 995
  • Industry report
  • July 2015
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Breast Cancer Partnering ...

Breast Cancer Treatment Drug  Markets in China

Breast Cancer Treatment Drug Markets in China

  • $ 4 000
  • Industry report
  • July 2015
  • by Asia Market Information & Development Company

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...

Metastatic Breast Cancer - Pipeline Review, H1 2015

Metastatic Breast Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Metastatic Breast Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s ...

Breast Cancer Drug Pipeline Update 2015

Breast Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, ...

 Hormone Refractory Breast Cancer-Pipeline Insights, 2015

Hormone Refractory Breast Cancer-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Hormone Refractory Breast Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Hormone Refractory Breast Cancer. The main objective ...

Physician Views: Have expectations been reset for Puma Biotechnology%s neratinib in HER2+ breast cancer?

Physician Views: Have expectations been reset for Puma Biotechnology%s neratinib in HER2+ breast cancer?

  • $ 695
  • Industry report
  • May 2015
  • by Firstword Pharma

Investors appear to be resetting their expectations for Puma Biotechnology's experimental HER2-positive breast cancer treatment neratinib. An abstract released last week – ahead of this year's ASCO ...

About 14 000 reports for Breast Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • February 2013
    230 pages
  • Cancer  

    Oncology  

    Breast Cancer  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.